Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies

Vaccine

Volumn 26, Issue 25, 2008, Pages 3103-3111

  van Drunen Littel van den Hurk, S ^a   Snider, M ^a   Thompson, P ^a   Latimer, L ^a   Babiuk, L A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

BHV 1; CpG; DNA vaccine; Neonates; Protein vaccine

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DNA PRIME TGD PROTEIN CPG OLIGODEOXYNUCLEOTIDE VACCINE; DNA VACCINE; EMULSIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; MATERNAL ANTIBODY; PEPTIDE VACCINE; PLACEBO; PLASMID TGD PROTEIN VACCINE; TGD PROTEIN CPG OLIGODEOXYNUCLEOTIDE VACCINE; TGD PROTEIN GPC OLIGODEOXYNUCLEOTIDE VACCINE; TGD PROTEIN VACCINE; TGD PROTEIN VSA3 VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; COW; CYTOKINE RELEASE; DRUG EFFICACY; EVALUATION; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; LAMB; NEWBORN; NONHUMAN; PLASMID; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; TH1 CELL; VACCINATION; VIRUS LOAD; WEIGHT REDUCTION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; MATERNAL-FETAL EXCHANGE; OLIGODEOXYRIBONUCLEOTIDES; PREGNANCY; VIRAL PROTEINS;

EID: 44749087069     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.02.018     Document Type: Article

References (45)

1. Engels M., and Ackermann M. Pathogenesis of ruminant herpesvirus infections. Vet Microbiol 53 1-2 (1996) 3-15
2. Siegrist C.A., and Lambert P.H. Immunization with DNA vaccines in early life: advantages and limitations as compared to conventional vaccines. Springer Semin Immunopathol 19 2 (1997) 233-243
3. Streilein J.W. Neonatal tolerance of H-2 alloantigens. Procuring graft acceptance the "old-fashioned" way. Transplantation 52 July (1) (1991) 1-10
4. Mor G., Yamshchikov G., Sedegah M., Takeno M., Wang R., Houghten R.A., et al. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin Invest 98 December 15 (12) (1996) 2700-2705
5. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.H., and Siegrist C.A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 26 July (7) (1996) 1489-1496
6. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 21 July 28 (24) (2003) 3406-3412
7. Fischer L., Barzu S., Andreoni C., Buisson N., Brun A., and Audonnet J.C. DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseudorabies virus challenge. Vaccine 21 April 2 (15) (2003) 1732-1741
8. Hassett D.E., Zhang J., and Whitton J.L. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J Virol 71 10 (1997) 7881-7888
9. Manickan E., Yu Z., and Rouse B.T. DNA immunization of neonates induces immunity despite the presence of maternal antibody. J Clin Invest 100 9 (1997) 2371-2375
10. Pertmer T.M., and Robinson H.L. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein. Virology 257 2 (1999) 406-414
11. Sarzotti M., Dean T.A., Remington M.P., Ly C.D., Furth P.A., and Robbins D.S. Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine 15 8 (1997) 795-797
12. van Drunen Littel-van den Hurk S., Braun R.P., Lewis P.J., Karvonen B.C., Babiuk L.A., and Griebel P.J. Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. Viral Immunol 12 1 (1999) 67-77
13. Monteil M., Le Potier M.F., Cariolet R., Houdayer C., and Eloit M. Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth. J Gen Virol 78 Pt 12 (1997) 3303-3310
14. Prince A.M., Whalen R., and Brotman B. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine 15 8 (1997) 916-919
15. Bot A. DNA vaccination and the immune responsiveness of neonates. Int Rev Immunol 19 2-3 (2000) 221-245
16. Bot A., Shearer M., Bot S., Woods C., Limmer J., Kennedy R., et al. Induction of antibody response by DNA immunization of newborn baboons against influenza virus. Viral Immunol 12 2 (1999) 91-96
17. Bagarazzi M.L., Boyer J.D., Javadian M.A., Chattergoon M., Dang K., Kim G., et al. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees. J Med Primatol 26 February-April (1-2) (1997) 27-33
18. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol 76 September (18) (2002) 9002-9010
19. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21 November 22 (1-2) (2002) 127-137
20. Roman M., Martin-Orozco E., Goodman J.S., Minh-Duc N., Sato Y., Ronaghy A., et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3 8 (1997) 849-854
21. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186 10 (1997) 1623-1631
22. Brazolot Millan C.L., Weeratna R., Krieg A.M., Siegrist C.A., and Davis H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci USA 95 26 (1998) 15553-15558
23. van Drunen Littel-van den H., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., et al. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J Gen Virol 79 Pt 4 (1998) 831-839
24. Kowalski J.K., Gilbert S.A., van Drunen Littel-van den Hurk S., van den Hurk J.V., Babiuk L.A., and Zamb T.J. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 11 (1993) 1100-1107
25. van Drunen Littel-van den Hurk S., Van Donkersgoed J., Kowalski J., van den Hurk J.V., Harland R., Babiuk L.A., et al. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12 14 (1994) 1295-1302
26. Pontarollo R.A., Babiuk L.A., Hecker R., and van Drunen Littel-Van Den Hurk S. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 83 December (Pt 12) (2002) 2973-2981
27. Raggo C., Habermehl M., Babiuk L.A., and Griebel P. The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma. J Gen Virol 81 Pt 11 (2000) 2665-2673
28. Song M.K., Lee S.W., Suh Y.S., Lee K.J., and Sung Y.C. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice. J Virol 74 6 (2000) 2920-2925
29. Weeratna R.D., Brazolot Millan C.L., McCluskie M.J., and Davis H.L. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. FEMS Immunol Med Microbiol 32 1 (2001) 65-71
30. Monteil M., Le Potier M.F., Guillotin J., Cariolet R., Houdayer C., and Eloit M. Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Vet Res 27 4-5 (1996) 443-452
31. Dunachie S.J., Walther M., Vuola J.M., Webster D.P., Keating S.M., Berthoud T., et al. A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS. Vaccine 24 April 5 (15) (2006) 2850-2859
32. McConkey S.J., Reece W.H., Moorthy V.S., Webster D., Dunachie S., Butcher G., et al. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 9 June (6) (2003) 729-735
33. Mwau M., Cebere I., Sutton J., Chikoti P., Winstone N., Wee E.G., et al. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J Gen Virol 85 April (Pt 4) (2004) 911-919
34. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 January 17 (6869) (2002) 331-335
35. Webster D.P., Dunachie S., McConkey S., Poulton I., Moore A.C., Walther M., et al. Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. Vaccine 24 April 5 (15) (2006) 3026-3034
36. Anson D.S. The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery. Genet Vaccines Ther 2 August 13 (1) (2004) 9
37. Pal R., Kalyanaraman V.S., Nair B.C., Whitney S., Keen T., Hocker L., et al. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype. Virology 348 May 10 (2) (2006) 341-353
38. Yu H., Babiuk L.A., and van Drunen Littel-van den Hurk S. Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3. J Gen Virol 85 June (Pt 6) (2004) 1533-1543
39. Galloway D., Liner A., Legutki J., Mateczun A., Barnewall R., and Estep J. Genetic immunization against anthrax. Vaccine 22 April 16 (13-14) (2004) 1604-1608
40. Li Z., Zhang H., Fan X., Zhang Y., Huang J., Liu Q., et al. DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine 24 May 22 (21) (2006) 4565-4568
41. Moore Q.C., Bosarge J.R., Quin L.R., and McDaniel L.S. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein. Vaccine 24 July 17 (29-30) (2006) 5755-5761
42. Liang R., van den Hurk J.V., Babiuk L.A., and van Drunen Littel-van den Hurk S. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. J Gen Virol 87 October (Pt 10) (2006) 2971-2982
43. Skinner M.A., Wedlock D.N., de Lisle G.W., Cooke M.M., Tascon R.E., Ferraz J.C., et al. The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. Infect Immun 73 July (7) (2005) 4441-4444
44. Nonnecke B.J., Waters W.R., Foote M.R., Palmer M.V., Miller B.L., Johnson T.E., et al. Development of an adult-like cell-mediated immune response in calves after early vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Dairy Sci 88 January (1) (2005) 195-210
45. Hope J.C., Thom M.L., Villarreal-Ramos B., Vordermeier H.M., Hewinson R.G., and Howard C.J. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin Exp Immunol 139 January (1) (2005) 48-56